Welcome to our dedicated page for HCM II Acquisition SEC filings (Ticker: HOND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching a 200-page SPAC filing just to confirm HCM II Acquisition Corp’s trust balance or extension deadline can drain hours. The company’s disclosures cover sponsor warrants, redemption windows, and complex deal mechanics that rarely appear in conventional corporate reports. Stock Titan’s AI turns that maze into a clear map—automatically highlighting the paragraphs that matter for a blank-check vehicle like HCM II Acquisition Corp (HOND).
Whether you need the latest HCM II Acquisition Corp quarterly earnings report 10-Q filing, an HCM II Acquisition Corp annual report 10-K simplified, or an HCM II Acquisition Corp 8-K material events explained, every document arrives seconds after it hits EDGAR. Our AI-powered summaries answer the real questions investors ask: How much cash sits in the trust? When does the combination deadline expire? Has a letter of intent been signed?
- 10-Q & 10-K – trust account detail, sponsor loans, and risk factors, all paired with "understanding HCM II Acquisition Corp SEC documents with AI" summaries.
- Form 4 – see HCM II Acquisition Corp insider trading Form 4 transactions and get real-time alerts for HCM II Acquisition Corp executive stock transactions Form 4.
- 8-K – instant explanations of merger announcements, PIPE financings, or deadline extensions.
- DEF 14A / S-4 – the full HCM II Acquisition Corp proxy statement executive compensation and vote details, decoded line by line.
Stop paging through PDFs. Our platform delivers HCM II Acquisition Corp SEC filings explained simply, complete with "HCM II Acquisition Corp earnings report filing analysis" and "HCM II Acquisition Corp Form 4 insider transactions real-time" alerts. Make confident decisions faster, armed with AI clarity and continuous updates.
HCM II and Terrestrial Energy are proposing a Business Combination that will domesticate HCM II as a Delaware corporation and rename it New Terrestrial Energy (to be styled Terrestrial Energy Inc.). Under the transaction, HCM II ordinary shares, warrants and units convert into New Terrestrial Common Shares and New Terrestrial Warrants on a one-for-one or fractionated basis, sponsor founder shares and private placement warrants convert as described, and Terrestrial security holders will receive up to 151,970,541 New Terrestrial Common Shares based on an assumed Exchange Ratio of 45.85.
The filing discloses a Trust Account balance of approximately $242,511,057.72, a contemplated PIPE financing (aggregate proceeds up to $50,000,000 subject to offset rights), Sponsor holdings of 5,675,000 New Terrestrial Common Shares and 4,275,000 New Terrestrial Warrants, reimbursable sponsor expenses of approximately $286,003.09, and multiple closing conditions including a VWAP test tied to the VanEck Uranium and Nuclear Energy ETF and a minimum Available Closing SPAC Cash of $150,000,000.
HCM II Acquisition Corp. proposes a business combination to domesticate as Delaware corporation and combine with Terrestrial Energy, creating New Terrestrial Energy. The transaction will convert HCM II securities into New Terrestrial Common Shares and New Terrestrial Warrants, cancel units and adjust holdings per the Domestication and Merger agreements. Key financing includes PIPE subscriptions intended to raise up to $50,000,000 (subject to offset if PIPE investors hold non-redeemed shares). The Sponsor currently holds 5,675,000 New Terrestrial Common Shares via a sponsor conversion and 4,275,000 Private Placement Warrants. Approximately $231,150,000 of net IPO proceeds were placed in the Trust Account. Closing is conditioned on customary regulatory, shareholder and financing conditions, including minimum Available Closing SPAC Cash of $150,000,000 and certain VWAP thresholds tied to the VanEck Uranium and Nuclear Energy ETF and lock-up vesting provisions. The proxy/prospectus discloses potential dilution from convertible notes, warrants, options and contingent value rights and lists extensive risk factors, procedures for public shareholder redemptions and governance changes under proposed Delaware organizational documents.
FAQ
What is the current stock price of HCM II Acquisition (HOND)?
What is the market cap of HCM II Acquisition (HOND)?
